Guangzhou Wondfo Biotech Co Ltd
SZSE:300482

Watchlist Manager
Guangzhou Wondfo Biotech Co Ltd Logo
Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
Watchlist
Price: 24.29 CNY -6.22% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Guangzhou Wondfo Biotech Co Ltd?
Write Note

Guangzhou Wondfo Biotech Co Ltd
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guangzhou Wondfo Biotech Co Ltd
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
Change in Working Capital
-ÂĄ1.2B
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Change in Working Capital
-ÂĄ623.6m
CAGR 3-Years
-39%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Change in Working Capital
-ÂĄ2B
CAGR 3-Years
-4%
CAGR 5-Years
-13%
CAGR 10-Years
-18%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Change in Working Capital
-ÂĄ9B
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Change in Working Capital
-ÂĄ901.4m
CAGR 3-Years
-7%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Change in Working Capital
-ÂĄ3.2B
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Guangzhou Wondfo Biotech Co Ltd
Glance View

Market Cap
11.5B CNY
Industry
Health Care

Guangzhou Wondfo Biotech Co., Ltd. engages in the manufacture and sale of biochemical reagents, medical products and diagnostic test kits. The company is headquartered in Guangzhou, Guangdong and currently employs 3,411 full-time employees. The company went IPO on 2015-06-30. According to the testing result, the Company' products can be divided into qualitative testing products and quantitative testing products. According to the usage, the Company' products include pregnancy testing series, infectious diseases testing series, drugs (drug abuse) testing series and chronic disease testing series. The firm's products are used in POCT, clinical test, field test and personal health management, among others.

Intrinsic Value
42.67 CNY
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Guangzhou Wondfo Biotech Co Ltd's Change in Working Capital?
Change in Working Capital
-1.2B CNY

Based on the financial report for Sep 30, 2024, Guangzhou Wondfo Biotech Co Ltd's Change in Working Capital amounts to -1.2B CNY.

What is Guangzhou Wondfo Biotech Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-12%

Over the last year, the Change in Working Capital growth was -6%.

Back to Top